Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01268605 · ClinicalTrials.gov registry record · Phase 3
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
A Phase 3 study, sponsored by Pearl Network.
- Completed
- Registry status
- Phase 3
- Development phase
- 341
- Enrollment target
NCT01268605 is a Phase 3 study that has completed, run by Pearl Network. The registered enrollment target is 341 participants.
The verdict
NCT01268605, a Phase 3 study, has completed, sponsored by Pearl Network.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 341 participants
- Enrollment target
Study Summary
Postoperative hypersensitivity (POH) is a problem for many patients as determined by the recent Practitioners Engaged in Applied Research and Learning (PEARL) study of POH following occlusal caries restoration. The objectives of this two-armed randomized comparative effectiveness research trial (RCERT) are to determine whether adding a resin modified glass ionomer liner (RMGI) reduces POH in dentin bonded Class I resin based composite (RBC) restorations, and to identify other factors (putative risk factors) that are associated with increased POH. The primary outcome of this study is the reduction/elimination of restoration POH as measured by clinical assessment (air stream) and patient-reports. Outcomes will be ascertained via the following specific aims: Specific Aim 1: To compare the reduction of hypersensitivity of study teeth by clinical measurement (air drying) and by patient-reported outcomes among the two treatment groups at three points in time: prior to restoration and at one and four weeks postrestoration. Specific Aim 2: To identify putative risk factors for POH (or factors associated with differences in POH) including: preoperative caries stage measured by the proposed American Dental Association (ADA) Caries Classification System (CCS), lesion depth as measured on the preoperative radiograph, dentin caries activity ranked on opening the lesion, preparation depth, and patient sleep bruxism status.
Interventions
- PROCEDURE Restoration with a dentin bonding agent (DBA)
- PROCEDURE Restoration with a resin modified glass ionomer liner (RMGI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01268605
The ClinicalTrials.gov registry entry for NCT01268605 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 341 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pearl Network, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Restoration with a dentin bonding agent (DBA) is the first listed.
NCT01268605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01268605 about?
NCT01268605 is a clinical study titled "Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial". Postoperative hypersensitivity (POH) is a problem for many patients as determined by the recent Practitioners Engaged in Applied Research and Learning (PEARL) study of POH following occlusal caries restoration. The objectives of this two-armed randomized comparative effectiveness research trial (RCE...
What is the current status of trial NCT01268605?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 341 participants. The study started on 2010-09. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01268605?
The interventions under investigation include: Restoration with a dentin bonding agent (DBA) (PROCEDURE), Restoration with a resin modified glass ionomer liner (RMGI) (PROCEDURE).
Who is sponsoring clinical trial NCT01268605?
This trial is sponsored by Pearl Network, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.